Xavis자비스

Xavis is shrinking and loss-making, with its share price down sharply over the past year and no profitable quarters visible in the trailing figures.

Xavis makes X-ray inspection systems for EV batteries, circuit boards, semiconductors and food screening. Trailing twelve-month revenue to H1 2026 was about ₩27.4B, with an operating loss of about ₩5.0B and a net loss of about ₩4.5B. Cash of about ₩7.0B and borrowings of about ₩0.07B are reported, and the stock closed at ₩910 on 2026-10-19, with a market value of about ₩28.0B.

What stands out

• Revenue fell 25.8% in 2025 to about ₩27.9B after a strong 2024 of ₩37.6B, and the trailing figures show revenue still near that lower level.
• Operating margin was -14.1% in 2025 and -18.4% on a trailing basis, so losses have continued into 2026.
• The balance sheet shows cash of about ₩7.0B against very low borrowings of about ₩0.07B, though free cash flow was negative at about -₩0.9B over the trailing period.
• The share price is down 37.7% over one year and 6% over one month, while it is up 13.3% over three months; the stock sits far above its 52-week low of ₩0 and well below its 52-week high of ₩1,993.
• Foreign ownership fell from 3.1% to 2.7% over the last 60 days, while retail and institutional investors were net sellers over the last 20 days.

What to watch

• A trading halt was filed on 2026-10-20 and another on 2026-09-18; the data does not explain the reason, so check the filings directly.
• A major sales or supply contract was filed on 2026-09-29; the contract size and terms are not in the data, so the impact on revenue is unclear.
• The next annual or quarterly results and whether operating losses narrow; the data contains no forecasts or analyst views.